Search results
EC conditionally approves Pfizer’s haemophilia B gene therapy
Pharmaceutical Technology· 1 day agoThe European Commission (EC) has awarded conditional marketing authorisation for Pfizer's DURVEQTIX...
Pfizer Announces Success In Hemophilia Gene Therapy In A Late-stage Trial
Times Now· 2 days agoPfizer has announced a successful large late-stage trial in experimental gene therapy for Hemophilia...
Pfizer reports positive data from trial of gene therapy for haemophilia A
Clinical Trials Arena· 2 days agoPfizer has reported positive data from the Phase III AFFINE clinical trial of investigational gene...
Pfizer's gene therapy cuts hemophilia A bleeding rate in late-stage trial - ET HealthWorld | Pharma
The Economic Times· 3 days agoLondon: Pfizer's gene therapy for hemophilia A significantly cut the number of annual bleeding...
Pfizer says hemophilia gene therapy meets late-stage study goal
BioPharma Dive· 3 days agoDive Brief: An experimental gene therapy from Pfizer succeeded in a Phase 3 study of people with...
MHRA approves Pfizer-BioNTech’s Comirnaty JN.1 vaccine
Pharmaceutical Technology· 2 days agoThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the use of Pfizer...
UK regulator authorises updated Pfizer-BioNTech COVID shot targeting JN.1 strain - ET HealthWorld |...
The Economic Times· 2 days agoLondon: Britain's health regulator said on Wednesday it has authorised Pfizer and BioNTech's updated...
Covid-19 vaccines: serious adverse events explained
Pharmaceutical Technology· 4 days agoIt said that a causal relationship between the vaccine and the disorder was "at least a reasonable possibility". Pfizer-BioNTech, Comirnaty The EMA has...
The benefits of glass packs for pharmaceuticals
Packaging Gateway· 4 days agoDrug giants Merck and Pfizer have teamed up with glass manufacturer Corning to create a solution for injectable drugs in vials and cartridges. Katie...
A new generation of weight loss drugs could radically change healthcare
Semafor· 2 days agoThree firms — Novo, Eli Lilly, and Pfizer — are working on weight-loss pills, rather than...